BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1751578)

  • 41. Cell-mediated immunity in children with Hodgkin's and non-Hodgkin's lymphomas.
    Eckschlager T; Jira M; Strejcek J
    Pediatr Hematol Oncol; 1991; 8(3):251-6. PubMed ID: 1742184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
    Sýkorová A; Belada D; Smolej L; Pytlík R; Benesová K; Vásová I; Papajík T; Sálek D; Procházka V; Matuska M; Brejcha M; Kubácková K; Kabícková E; Móciková H; Campr V; Trnený M;
    Klin Onkol; 2010; 23(3):146-54. PubMed ID: 20608324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consultation with the specialist: lymphomas.
    Velez MC
    Pediatr Rev; 2003 Nov; 24(11):380-6. PubMed ID: 14595035
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Progress of radiation therapy in malignant lymphomas].
    Kaneta K; Nakazawa N; Kawabata K; Hashida J; Kawaguchi T; Yamashita T
    Gan No Rinsho; 1988 Apr; 34(5):555-64. PubMed ID: 3385921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
    Glińska H; Papla B; Siuda M; Zulichowska J
    Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
    García R; Hernández JM; Caballero MD; González M; Galende J; del Cañizo MC; Vázquez L; San Miguel JF
    Br J Cancer; 1993 Dec; 68(6):1227-31. PubMed ID: 8260377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Malignant lymphoma of the neck, nose and pharyngeal region].
    Cerny T
    Schweiz Rundsch Med Prax; 1993 Dec; 82(50):1447-51. PubMed ID: 8290837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    Nachman J
    Am J Pediatr Hematol Oncol; 1990; 12(3):359-66. PubMed ID: 2240485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Strategies in the treatment of non-Hodgkin's lymphomas].
    Brittinger G; Meusers P; Engelhard M
    Internist (Berl); 1986 Aug; 27(8):485-97. PubMed ID: 3531069
    [No Abstract]   [Full Text] [Related]  

  • 55. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
    Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
    Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities].
    Tomita T; Fujii M; Imanishi Y; Kanke M; Kanzaki J; Ohno Y; Tokumaru Y; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Jun; 102(6):809-17. PubMed ID: 10429435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
    Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
    Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience.
    Nachbaur D; Oberaigner W; Fritsch E; Nussbaumer W; Gastl G
    Eur J Haematol; 2001 Jan; 66(1):43-9. PubMed ID: 11168507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy of non-Hodgkin's aggressive lymphomas.
    Salles G; Shipp MA; Coiffier B
    Semin Hematol; 1994 Jan; 31(1):46-69. PubMed ID: 8122135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.